$PVCT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PROVECTUS BIOPHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PROVECTUS BIOPHARMACEUTICALS, INC.. Get notifications about new insider transactions in PROVECTUS BIOPHARMACEUTICALS, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 18 2010 | PVCT | PROVECTUS BIOPHARM ... | McMasters Kelly M | Director | Option Exercise | A | 1.16 | 50,000 | 58,000 | 50,000 | |
Jun 18 2010 | PVCT | PROVECTUS BIOPHARM ... | FUCHS STUART | Director | Option Exercise | A | 1.16 | 50,000 | 58,000 | 50,000 | |
Jun 18 2010 | PVCT | PROVECTUS BIOPHARM ... | DEES H CRAIG | Chief Executive Off ... | Option Exercise | A | 1.16 | 50,000 | 58,000 | 50,000 | |
Apr 29 2010 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | M | 0.75 | 52,419 | 39,314 | 247,581 | |
Apr 29 2010 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | M | 0.64 | 105,469 | 67,500 | 0 | |
Apr 29 2010 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Buy | M | 0.75 | 52,419 | 39,314 | 2,968,237 | 2.9 M to 3 M (+1.80 %) |
Apr 29 2010 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Buy | M | 0.64 | 105,469 | 67,500 | 2,915,818 | 2.8 M to 2.9 M (+3.75 %) |
Dec 23 2009 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | M | 1.02 | 15,000 | 15,300 | 985,000 | |
Dec 23 2009 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | M | 0.94 | 83,334 | 78,334 | 0 | |
Dec 23 2009 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Buy | M | 1.02 | 15,000 | 15,300 | 2,810,349 | 2.8 M to 2.8 M (+0.54 %) |
Dec 23 2009 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Buy | M | 0.94 | 83,334 | 78,334 | 2,795,349 | 2.7 M to 2.8 M (+3.07 %) |
Aug 27 2009 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | M | 0.94 | 50,000 | 47,000 | 83,334 | |
Aug 27 2009 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Buy | M | 0.94 | 50,000 | 47,000 | 2,712,015 | 2.7 M to 2.7 M (+1.88 %) |
Jul 20 2009 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | M | 1.02 | 20,000 | 20,400 | 1,000,000 | |
Jul 20 2009 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Buy | M | 1.02 | 20,000 | 20,400 | 2,662,015 | 2.6 M to 2.7 M (+0.76 %) |
Jul 08 2009 | PVCT | PROVECTUS BIOPHARM ... | FUCHS STUART | Director | Grant | A | 0.00 | 70,000 | 0 | 871,418 | 801.4 K to 871.4 K (+8.73 %) |
Jun 09 2009 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | M | 0.64 | 109,375 | 70,000 | 105,469 | |
Jun 09 2009 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Buy | M | 0.64 | 109,375 | 70,000 | 2,642,015 | 2.5 M to 2.6 M (+4.32 %) |
Jun 19 2009 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | A | 1.04 | 50,000 | 52,000 | 50,000 | |
Jun 19 2009 | PVCT | PROVECTUS BIOPHARM ... | SCOTT TIMOTHY PHD | President | Option Exercise | A | 1.04 | 50,000 | 52,000 | 50,000 | |
Jun 19 2009 | PVCT | PROVECTUS BIOPHARM ... | McMasters Kelly M | Director | Option Exercise | A | 1.04 | 50,000 | 52,000 | 50,000 | |
Jun 19 2009 | PVCT | PROVECTUS BIOPHARM ... | FUCHS STUART | Director | Option Exercise | A | 1.04 | 50,000 | 52,000 | 50,000 | |
Jun 19 2009 | PVCT | PROVECTUS BIOPHARM ... | DEES H CRAIG | Chief Executive Off ... | Option Exercise | A | 1.04 | 50,000 | 52,000 | 50,000 | |
Jun 11 2009 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Option Exercise | M | 0.64 | 150,000 | 96,000 | 0 | |
Jun 11 2009 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Buy | M | 0.64 | 150,000 | 96,000 | 410,376 | 260.4 K to 410.4 K (+57.61 %) |
Apr 02 2009 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | M | 0.64 | 46,875 | 30,000 | 214,844 | |
Apr 02 2009 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Buy | M | 0.64 | 46,875 | 30,000 | 2,532,640 | 2.5 M to 2.5 M (+1.89 %) |
Nov 24 2008 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | M | 0.94 | 66,666 | 62,666 | 133,334 | |
Nov 24 2008 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Buy | M | 0.94 | 66,666 | 62,666 | 2,485,765 | 2.4 M to 2.5 M (+2.76 %) |
Jul 01 2008 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Executive VP Pharma ... | Option Exercise | A | 1.00 | 50,000 | 50,000 | 50,000 | |
Jul 01 2008 | PVCT | PROVECTUS BIOPHARM ... | FUCHS STUART | Director | Option Exercise | A | 1.00 | 50,000 | 50,000 | 50,000 | |
Jul 01 2008 | PVCT | PROVECTUS BIOPHARM ... | SCOTT TIMOTHY PHD | President | Option Exercise | A | 1.00 | 50,000 | 50,000 | 50,000 | |
Jul 01 2008 | PVCT | PROVECTUS BIOPHARM ... | DEES H CRAIG | Chief Executive Off ... | Option Exercise | A | 1.00 | 50,000 | 50,000 | 50,000 | |
Jun 25 2008 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Executive VP Pharma ... | Option Exercise | M | 1.02 | 30,000 | 30,600 | 1,020,000 | |
Jun 25 2008 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Executive VP Pharma ... | Buy | M | 1.02 | 30,000 | 30,600 | 2,419,099 | 2.4 M to 2.4 M (+1.26 %) |
Jun 16 2008 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Option Exercise | M | 1.10 | 44,795 | 49,275 | 189,624 | |
Jun 16 2008 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Buy | M | 1.10 | 44,795 | 49,275 | 110,376 | 65.6 K to 110.4 K (+68.30 %) |
Jun 05 2008 | PVCT | PROVECTUS BIOPHARM ... | McMasters Kelly M | Director | Option Exercise | M | 1.16 | 10,000 | 11,600 | 10,000 | |
Jun 05 2008 | PVCT | PROVECTUS BIOPHARM ... | McMasters Kelly M | Director | Option Exercise | M | 1.16 | 50,000 | 58,000 | 50,000 | |
May 30 2008 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Executive VP Pharma ... | Option Exercise | M | 0.62 | 25,000 | 15,500 | 0 | |
May 30 2008 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Executive VP Pharma ... | Option Exercise | M | 0.64 | 38,281 | 24,500 | 261,719 | |
May 30 2008 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Executive VP Pharma ... | Buy | M | 0.62 | 25,000 | 15,500 | 2,389,099 | 2.4 M to 2.4 M (+1.06 %) |
May 30 2008 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Executive VP Pharma ... | Buy | M | 0.64 | 38,281 | 24,500 | 2,364,099 | 2.3 M to 2.4 M (+1.65 %) |
Apr 10 2008 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | M | 0.32 | 75,000 | 24,000 | 0 | |
Apr 10 2008 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | M | 0.60 | 25,000 | 15,000 | 0 | |
Apr 10 2008 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Buy | M | 0.60 | 25,000 | 15,000 | 2,325,818 | 2.3 M to 2.3 M (+1.09 %) |
Apr 10 2008 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Buy | M | 0.32 | 75,000 | 24,000 | 2,300,818 | 2.2 M to 2.3 M (+3.37 %) |
Dec 27 2007 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | M | 0.94 | 330,881 | 309,374 | 0 | |
Dec 27 2007 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Buy | M | 0.94 | 330,881 | 309,374 | 2,225,818 | 1.9 M to 2.2 M (+17.46 %) |
Nov 14 2007 | PVCT | PROVECTUS BIOPHARM ... | DEES H CRAIG | Chief Executive Off ... | Option Exercise | M | 0.32 | 6,250 | 2,000 | 18,750 | |
Nov 14 2007 | PVCT | PROVECTUS BIOPHARM ... | DEES H CRAIG | Chief Executive Off ... | Buy | M | 0.32 | 6,250 | 2,000 | 1,454,109 | 1.4 M to 1.5 M (+0.43 %) |
Nov 13 2007 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Option Exercise | M | 0.64 | 50,000 | 32,000 | 150,000 | |
Nov 13 2007 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Buy | M | 0.64 | 50,000 | 32,000 | 215,581 | 165.6 K to 215.6 K (+30.20 %) |
Sep 24 2007 | PVCT | PROVECTUS BIOPHARM ... | ADAMS DONALD E | 10% Owner | Option Exercise | C | 0.74 | 547,384 | 403,422 | 0 | |
Sep 24 2007 | PVCT | PROVECTUS BIOPHARM ... | ADAMS DONALD E | 10% Owner | Sell | S | 2.98 | 5,000 | 14,900 | 5,526,123 | 5.5 M to 5.5 M (-0.09 %) |
Sep 24 2007 | PVCT | PROVECTUS BIOPHARM ... | ADAMS DONALD E | 10% Owner | Sell | S | 2.90 | 5,000 | 14,500 | 5,531,123 | 5.5 M to 5.5 M (-0.09 %) |
Sep 24 2007 | PVCT | PROVECTUS BIOPHARM ... | ADAMS DONALD E | 10% Owner | Sell | S | 2.89 | 5,000 | 14,450 | 5,536,123 | 5.5 M to 5.5 M (-0.09 %) |
Sep 24 2007 | PVCT | PROVECTUS BIOPHARM ... | ADAMS DONALD E | 10% Owner | Sell | S | 2.99 | 5,000 | 14,950 | 5,541,123 | 5.5 M to 5.5 M (-0.09 %) |
Sep 24 2007 | PVCT | PROVECTUS BIOPHARM ... | ADAMS DONALD E | 10% Owner | Sell | S | 2.86 | 5,000 | 14,300 | 5,546,123 | 5.6 M to 5.5 M (-0.09 %) |
Sep 24 2007 | PVCT | PROVECTUS BIOPHARM ... | ADAMS DONALD E | 10% Owner | Sell | S | 2.80 | 50,000 | 140,000 | 5,551,123 | 5.6 M to 5.6 M (-0.89 %) |
Sep 24 2007 | PVCT | PROVECTUS BIOPHARM ... | ADAMS DONALD E | 10% Owner | Sell | S | 2.40 | 25,000 | 60,000 | 5,601,123 | 5.6 M to 5.6 M (-0.44 %) |
Sep 24 2007 | PVCT | PROVECTUS BIOPHARM ... | ADAMS DONALD E | 10% Owner | Sell | S | 2.08 | 20,000 | 41,500 | 5,626,123 | 5.6 M to 5.6 M (-0.35 %) |
Sep 24 2007 | PVCT | PROVECTUS BIOPHARM ... | ADAMS DONALD E | 10% Owner | Sell | S | 1.45 | 630 | 914 | 5,646,123 | 5.6 M to 5.6 M (-0.01 %) |
Sep 24 2007 | PVCT | PROVECTUS BIOPHARM ... | ADAMS DONALD E | 10% Owner | Sell | S | 1.47 | 4,000 | 5,880 | 5,646,753 | 5.7 M to 5.6 M (-0.07 %) |
Sep 24 2007 | PVCT | PROVECTUS BIOPHARM ... | ADAMS DONALD E | 10% Owner | Sell | S | 1.29 | 2,000 | 2,580 | 5,650,753 | 5.7 M to 5.7 M (-0.04 %) |
Sep 24 2007 | PVCT | PROVECTUS BIOPHARM ... | ADAMS DONALD E | 10% Owner | Sell | S | 1.24 | 2,000 | 2,480 | 5,652,753 | 5.7 M to 5.7 M (-0.04 %) |
Sep 24 2007 | PVCT | PROVECTUS BIOPHARM ... | ADAMS DONALD E | 10% Owner | Sell | S | 1.15 | 4,000 | 4,600 | 5,654,753 | 5.7 M to 5.7 M (-0.07 %) |
Sep 24 2007 | PVCT | PROVECTUS BIOPHARM ... | ADAMS DONALD E | 10% Owner | Sell | S | 1.14 | 2,000 | 2,280 | 5,658,753 | 5.7 M to 5.7 M (-0.04 %) |
Sep 24 2007 | PVCT | PROVECTUS BIOPHARM ... | ADAMS DONALD E | 10% Owner | Sell | S | 1.14 | 2,000 | 2,280 | 5,660,753 | 5.7 M to 5.7 M (-0.04 %) |
Sep 24 2007 | PVCT | PROVECTUS BIOPHARM ... | ADAMS DONALD E | 10% Owner | Sell | S | 1.13 | 2,000 | 2,260 | 5,662,753 | 5.7 M to 5.7 M (-0.04 %) |
Sep 24 2007 | PVCT | PROVECTUS BIOPHARM ... | ADAMS DONALD E | 10% Owner | Sell | S | 1.12 | 8,000 | 8,960 | 5,664,753 | 5.7 M to 5.7 M (-0.14 %) |
Sep 24 2007 | PVCT | PROVECTUS BIOPHARM ... | ADAMS DONALD E | 10% Owner | Sell | S | 1.15 | 4,772 | 5,488 | 5,672,753 | 5.7 M to 5.7 M (-0.08 %) |
Sep 24 2007 | PVCT | PROVECTUS BIOPHARM ... | ADAMS DONALD E | 10% Owner | Sell | S | 1.13 | 4,000 | 4,520 | 5,677,525 | 5.7 M to 5.7 M (-0.07 %) |
Sep 24 2007 | PVCT | PROVECTUS BIOPHARM ... | ADAMS DONALD E | 10% Owner | Sell | S | 1.17 | 2,000 | 2,340 | 5,681,525 | 5.7 M to 5.7 M (-0.04 %) |
Sep 24 2007 | PVCT | PROVECTUS BIOPHARM ... | ADAMS DONALD E | 10% Owner | Buy | P | 1.05 | 679,048 | 713,000 | 5,683,525 | 5 M to 5.7 M (+13.57 %) |
Sep 24 2007 | PVCT | PROVECTUS BIOPHARM ... | ADAMS DONALD E | 10% Owner | Sell | S | 1.20 | 1,500 | 1,800 | 5,004,477 | 5 M to 5 M (-0.03 %) |
Sep 24 2007 | PVCT | PROVECTUS BIOPHARM ... | ADAMS DONALD E | 10% Owner | Sell | S | 1.20 | 6,000 | 7,200 | 5,005,977 | 5 M to 5 M (-0.12 %) |
Sep 24 2007 | PVCT | PROVECTUS BIOPHARM ... | ADAMS DONALD E | 10% Owner | Sell | S | 1.23 | 2,000 | 2,460 | 5,011,977 | 5 M to 5 M (-0.04 %) |
Sep 24 2007 | PVCT | PROVECTUS BIOPHARM ... | ADAMS DONALD E | 10% Owner | Sell | S | 1.22 | 6,000 | 7,320 | 5,013,977 | 5 M to 5 M (-0.12 %) |
Sep 24 2007 | PVCT | PROVECTUS BIOPHARM ... | ADAMS DONALD E | 10% Owner | Sell | S | 1.13 | 15,000 | 16,950 | 5,019,977 | 5 M to 5 M (-0.30 %) |
Sep 24 2007 | PVCT | PROVECTUS BIOPHARM ... | ADAMS DONALD E | 10% Owner | Buy | C | 0.00 | 28,727 | 0 | 5,034,977 | 5 M to 5 M (+0.57 %) |
Sep 24 2007 | PVCT | PROVECTUS BIOPHARM ... | ADAMS DONALD E | 10% Owner | Buy | C | 0.74 | 518,657 | 382,250 | 5,006,250 | 4.5 M to 5 M (+11.56 %) |
Sep 13 2007 | PVCT | PROVECTUS BIOPHARM ... | DEES H CRAIG | Chief Executive Off ... | Option Exercise | M | 0.32 | 9,375 | 3,000 | 25,000 | |
Sep 13 2007 | PVCT | PROVECTUS BIOPHARM ... | DEES H CRAIG | Chief Executive Off ... | Buy | M | 0.32 | 9,375 | 3,000 | 1,447,859 | 1.4 M to 1.4 M (+0.65 %) |
Sep 13 2007 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Option Exercise | M | 0.64 | 25,000 | 16,000 | 200,000 | |
Sep 13 2007 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Buy | M | 0.64 | 25,000 | 16,000 | 165,581 | 140.6 K to 165.6 K (+17.78 %) |
Aug 24 2007 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Option Exercise | M | 0.64 | 75,000 | 48,000 | 225,000 | |
Aug 24 2007 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Buy | M | 0.64 | 75,000 | 48,000 | 140,581 | 65.6 K to 140.6 K (+114.36 %) |
Aug 24 2007 | PVCT | PROVECTUS BIOPHARM ... | DEES H CRAIG | Chief Executive Off ... | Option Exercise | M | 0.32 | 9,375 | 3,000 | 34,375 | |
Aug 24 2007 | PVCT | PROVECTUS BIOPHARM ... | DEES H CRAIG | Chief Executive Off ... | Buy | M | 0.32 | 9,375 | 3,000 | 1,438,484 | 1.4 M to 1.4 M (+0.66 %) |
Jul 02 2007 | PVCT | PROVECTUS BIOPHARM ... | DEES H CRAIG | Chief Executive Off ... | Option Exercise | M | 0.32 | 6,250 | 2,000 | 43,750 | |
Jul 02 2007 | PVCT | PROVECTUS BIOPHARM ... | DEES H CRAIG | Chief Executive Off ... | Buy | M | 0.32 | 6,250 | 2,000 | 1,429,109 | 1.4 M to 1.4 M (+0.44 %) |
Jun 25 2007 | PVCT | PROVECTUS BIOPHARM ... | FUCHS STUART | Director | Option Exercise | A | 1.50 | 50,000 | 75,000 | 50,000 | |
Jun 25 2007 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | A | 1.50 | 50,000 | 75,000 | 50,000 | |
Jun 25 2007 | PVCT | PROVECTUS BIOPHARM ... | DEES H CRAIG | Chief Executive Off ... | Option Exercise | A | 1.50 | 50,000 | 75,000 | 50,000 | |
Jun 25 2007 | PVCT | PROVECTUS BIOPHARM ... | SCOTT TIMOTHY PHD | President | Option Exercise | A | 1.50 | 50,000 | 75,000 | 50,000 | |
Mar 09 2007 | PVCT | PROVECTUS BIOPHARM ... | DEES H CRAIG | Chief Executive Off ... | Option Exercise | M | 0.32 | 9,375 | 3,000 | 50,000 | |
Mar 09 2007 | PVCT | PROVECTUS BIOPHARM ... | DEES H CRAIG | Chief Executive Off ... | Buy | M | 0.32 | 9,375 | 3,000 | 1,422,859 | 1.4 M to 1.4 M (+0.66 %) |
Feb 15 2007 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | M | 1.10 | 120,920 | 133,012 | 75,000 | |
Feb 15 2007 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Buy | M | 1.10 | 120,920 | 133,012 | 1,894,937 | 1.8 M to 1.9 M (+6.82 %) |
Nov 30 2006 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Option Exercise | M | 1.10 | 3,500 | 3,850 | 224,419 | |
Nov 30 2006 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Buy | M | 1.10 | 3,500 | 3,850 | 65,581 | 62.1 K to 65.6 K (+5.64 %) |
Oct 31 2006 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Option Exercise | M | 1.10 | 3,500 | 3,850 | 237,919 | |
Oct 31 2006 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Buy | M | 1.10 | 3,500 | 3,850 | 62,081 | 58.6 K to 62.1 K (+5.97 %) |
Oct 02 2006 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Option Exercise | M | 1.10 | 3,500 | 3,850 | 241,419 | |
Oct 02 2006 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Buy | M | 1.10 | 3,500 | 3,850 | 58,581 | 55.1 K to 58.6 K (+6.35 %) |
Aug 31 2006 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Option Exercise | M | 1.10 | 3,500 | 3,850 | 244,919 | |
Aug 31 2006 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Buy | M | 1.10 | 3,500 | 3,850 | 55,081 | 51.6 K to 55.1 K (+6.79 %) |
Aug 01 2006 | PVCT | PROVECTUS BIOPHARM ... | DEES H CRAIG | Chief Executive Off ... | Option Exercise | M | 0.32 | 3,125 | 1,000 | 59,375 | |
Aug 01 2006 | PVCT | PROVECTUS BIOPHARM ... | DEES H CRAIG | Chief Executive Off ... | Buy | M | 0.32 | 3,125 | 1,000 | 1,413,484 | 1.4 M to 1.4 M (+0.22 %) |
Jul 31 2006 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Option Exercise | M | 1.10 | 3,500 | 3,850 | 248,419 | |
Jul 31 2006 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Buy | M | 1.10 | 3,500 | 3,850 | 51,581 | 48.1 K to 51.6 K (+7.28 %) |
Jul 06 2006 | PVCT | PROVECTUS BIOPHARM ... | FUCHS STUART | Director | Option Exercise | A | 1.02 | 50,000 | 51,000 | 50,000 | |
Jul 06 2006 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Option Exercise | M | 1.10 | 3,500 | 3,850 | 251,919 | |
Jul 06 2006 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Buy | M | 1.10 | 3,500 | 3,850 | 48,081 | 44.6 K to 48.1 K (+7.85 %) |
Jun 26 2006 | PVCT | PROVECTUS BIOPHARM ... | SCOTT TIMOTHY PHD | President | Option Exercise | A | 1.02 | 1,000,000 | 1,020,000 | 1,050,000 | |
Jun 26 2006 | PVCT | PROVECTUS BIOPHARM ... | SCOTT TIMOTHY PHD | President | Option Exercise | A | 1.02 | 50,000 | 51,000 | 50,000 | |
Jun 26 2006 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | A | 1.02 | 1,000,000 | 1,020,000 | 1,050,000 | |
Jun 26 2006 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | A | 1.02 | 50,000 | 51,000 | 50,000 | |
Jun 26 2006 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Option Exercise | A | 1.02 | 1,000,000 | 1,020,000 | 1,000,000 | |
Jun 26 2006 | PVCT | PROVECTUS BIOPHARM ... | DEES H CRAIG | Chief Executive Off ... | Option Exercise | A | 1.02 | 1,000,000 | 1,020,000 | 1,050,000 | |
Jun 26 2006 | PVCT | PROVECTUS BIOPHARM ... | DEES H CRAIG | Chief Executive Off ... | Option Exercise | A | 1.02 | 50,000 | 51,000 | 50,000 | |
May 31 2006 | PVCT | PROVECTUS BIOPHARM ... | ADAMS DONALD E | 10% Owner | Buy | P | 1.54 | 20,000 | 30,800 | 6,656,250 | 6.6 M to 6.7 M (+0.30 %) |
May 31 2006 | PVCT | PROVECTUS BIOPHARM ... | ADAMS DONALD E | 10% Owner | Buy | P | 1.60 | 20,000 | 32,000 | 6,636,250 | 6.6 M to 6.6 M (+0.30 %) |
Jun 06 2006 | PVCT | PROVECTUS BIOPHARM ... | DEES H CRAIG | Chief Executive Off ... | Option Exercise | M | 0.32 | 6,250 | 2,000 | 62,510 | |
Jun 06 2006 | PVCT | PROVECTUS BIOPHARM ... | DEES H CRAIG | Chief Executive Off ... | Buy | M | 0.32 | 6,250 | 2,000 | 1,410,359 | 1.4 M to 1.4 M (+0.45 %) |
Jun 01 2006 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Option Exercise | M | 1.10 | 3,500 | 3,850 | 255,419 | |
Jun 01 2006 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Option Exercise | M | 1.10 | 3,666 | 4,033 | 258,919 | |
Jun 01 2006 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Buy | M | 1.10 | 3,500 | 3,850 | 44,581 | 41.1 K to 44.6 K (+8.52 %) |
Jun 01 2006 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Buy | M | 1.10 | 3,666 | 4,033 | 41,081 | 37.4 K to 41.1 K (+9.80 %) |
May 31 2006 | PVCT | PROVECTUS BIOPHARM ... | DEES H CRAIG | Chief Executive Off ... | Option Exercise | M | 0.32 | 3,125 | 1,000 | 68,760 | |
May 31 2006 | PVCT | PROVECTUS BIOPHARM ... | DEES H CRAIG | Chief Executive Off ... | Buy | M | 0.32 | 3,125 | 1,000 | 1,404,109 | 1.4 M to 1.4 M (+0.22 %) |
Apr 25 2006 | PVCT | PROVECTUS BIOPHARM ... | DEES H CRAIG | Chief Executive Off ... | Option Exercise | M | 0.32 | 3,125 | 1,000 | 71,875 | |
Apr 25 2006 | PVCT | PROVECTUS BIOPHARM ... | DEES H CRAIG | Chief Executive Off ... | Buy | M | 0.32 | 3,125 | 1,000 | 1,950,984 | 1.9 M to 2 M (+0.16 %) |
Mar 31 2006 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Option Exercise | M | 1.10 | 3,666 | 4,033 | 262,585 | |
Mar 31 2006 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Buy | M | 1.10 | 3,666 | 4,033 | 37,415 | 33.7 K to 37.4 K (+10.86 %) |
Mar 31 2006 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | M | 1.10 | 22,398 | 24,638 | 195,920 | |
Mar 31 2006 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Buy | M | 1.10 | 22,398 | 24,638 | 1,774,017 | 1.8 M to 1.8 M (+1.28 %) |
Mar 01 2006 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Option Exercise | M | 1.10 | 3,734 | 4,107 | 266,251 | |
Mar 01 2006 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Buy | M | 1.10 | 3,734 | 4,107 | 33,749 | 30 K to 33.7 K (+12.44 %) |
Jan 31 2006 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Option Exercise | M | 1.10 | 3,499 | 3,849 | 269,985 | |
Jan 31 2006 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Buy | M | 1.10 | 3,499 | 3,849 | 30,015 | 26.5 K to 30 K (+13.20 %) |
Jan 31 2006 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | M | 1.10 | 39,703 | 43,673 | 218,318 | |
Jan 31 2006 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Buy | M | 1.10 | 39,703 | 43,673 | 1,751,619 | 1.7 M to 1.8 M (+2.32 %) |
Jan 04 2006 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | M | 1.10 | 41,979 | 46,177 | 258,021 | |
Jan 04 2006 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Buy | M | 1.10 | 41,979 | 46,177 | 1,711,916 | 1.7 M to 1.7 M (+2.51 %) |
Jan 03 2006 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Option Exercise | M | 1.10 | 3,788 | 4,167 | 273,484 | |
Jan 03 2006 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Buy | M | 1.10 | 3,788 | 4,167 | 26,516 | 22.7 K to 26.5 K (+16.67 %) |
Dec 12 2005 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Option Exercise | A | 0.94 | 330,881 | 309,374 | 330,881 | |
Dec 12 2005 | PVCT | PROVECTUS BIOPHARM ... | WACHTER ERIC PHD | Vice President Phar ... | Buy | P | 0.75 | 264,705 | 198,529 | 1,669,937 | 1.4 M to 1.7 M (+18.84 %) |